Invesaro

Stocks Technology CDLX

NASDAQ · Technology

Cardlytics, Inc. (CDLX)

Cardlytics, Inc. brought in $190M of revenue over the twelve months to June 30, 2026, down 25.6% from a year earlier. It posted a net loss of $100.3M. Operating cash flow minus capital spending left $8.8M of free cash flow in fiscal 2025. At June 30, 2026 it held $28M in cash against $184.4M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 5, 2026.

Watch CDLX in 60 seconds
Price
$3.30
-4.35% on the day · September 25, 2026
52-week range $3.21 to $27.10
Market cap
$19.4M
Revenue (last 12 months)
$190M
-25.6% year on year
Net margin
-52.8%

What Cardlytics, Inc. does

Cardlytics, Inc. is registered with the SEC under industry code SIC 7370 (Services-Computer Programming, Data Processing, Etc.). Its shares trade on NASDAQ under the ticker CDLX.

Revenue and profit by year

Revenue
FY18: $150.7M $150.7M FY18FY19: $210.4M $210.4M FY19FY20: $186.9M $186.9M FY20FY21: $267.1M $267.1M FY21FY22: $298.5M $298.5M FY22FY23: $309.2M $309.2M FY23FY24: $278.3M $278.3M FY24FY25: $233.3M $233.3M FY25
Net income
FY18: -$53M -$53M FY18FY19: -$17.1M -$17.1M FY19FY20: -$55.4M -$55.4M FY20FY21: -$128.6M -$128.6M FY21FY22: -$465.3M -$465.3M FY22FY23: -$134.7M -$134.7M FY23FY24: -$189.3M -$189.3M FY24FY25: -$103.5M -$103.5M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$233.3M-$101.8M-$103.5M-$1.95$8.8M
2024$278.3M-$195.5M-$189.3M-$3.91-$10.4M
2023$309.2M-$135.7M-$134.7M-$3.69-$852K
2022$298.5M-$457.8M-$465.3M-$13.92-$55.1M
2021$267.1M-$122.6M-$128.6M-$3.99-$41.6M
2020$186.9M-$53.9M-$55.4M-$2.04-$13M

Full financial statements: income, balance sheet and cash flow

Next report expected around November 4, 2026.

Estimated from its filing rhythm: 52 weeks after its report of November 5, 2025. Not a date the company has announced. See the report calendar

Where CDLX ranks in Technology

Revenue$233.3M
#384 of 638 in Technology · Bottom 40%
Revenue growth-16.2%
#521 of 554 in Technology · Bottom 6%
Net margin-44.4%
#494 of 560 in Technology · Bottom 12%
Free cash flow margin3.8%
#342 of 526 in Technology · Bottom 35%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Technology

Latest SEC filings

What Cardlytics, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. September 11, 2026
  2. August 5, 2026
    Quarterly report 10-Q · period to June 30, 2026Revenue fell 36% to $36.9M versus the same quarter last year; net loss of $14.9M.
  3. August 5, 2026
  4. June 3, 2026
  5. May 20, 2026
  6. May 12, 2026
  7. May 7, 2026
    Quarterly report 10-Q · period to March 31, 2026Revenue fell 39% to $34.3M versus the same quarter last year; net loss of $4.5M.
  8. May 7, 2026
  9. April 9, 2026
  10. April 9, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on August 24, 2026. Insider transactions on SEC

What is CDLX worth? A DCF from its reported cash flow

Insider trades

What the people running Cardlytics, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.

Insiders sold $53.8K worth of shares in the last 90 days and bought none on the open market.

Bought (open market)
$0
last 90 days
Sold
$53.8K
last 90 days
Net sold
13,461
$53.8K
DateInsiderWhatSharesPriceValueFiling
August 18, 2026 Gupta AmitChief Executive Officer, Director Sold 6,676 $4.03 $26.9K Form 4
August 17, 2026 Gupta AmitChief Executive Officer, Director Sold 6,785 $3.97 $26.9K Form 4
August 16, 2026 Gupta AmitChief Executive Officer, Director Exercised options 12,500 - - Form 4
August 16, 2026 Gupta AmitChief Executive Officer, Director Exercised options 12,500 - - Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns CDLX

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

HolderOf classSharesFiled
CAS Investment Partners, LLC13D, may seek influence with 4 related filers 9.8% 5,198,067 August 20, 2025

Latest filings below 5%: The Vanguard Group 4.6% (July 29, 2025).

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

1 insiders reported holding 125,389 shares in total, about $413.8K at the last price.

HolderSharesAs of
Gupta AmitChief Executive Officer, Director 125,389 August 18, 2026

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about CDLX

What does Cardlytics, Inc. do?

Cardlytics, Inc. is registered with the SEC under industry code SIC 7370 (Services-Computer Programming, Data Processing, Etc.). Its shares trade on NASDAQ under the ticker CDLX.

Is Cardlytics, Inc. profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $100.3M on revenue of $190M.

How much revenue does Cardlytics, Inc. make?

Over the twelve months to June 30, 2026 Cardlytics, Inc. reported revenue of $190M. That is 25.6% less than a year earlier.

When did Cardlytics, Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 5, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the material agreement from September 11, 2026.

Similar companies

Compare CDLX with

Compare CDLX with any company

Follow CDLX

Get an email when Cardlytics, Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow CDLX: get an email when it files

Where the numbers come from

Financial figures are the values Cardlytics, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.